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Cellular reprogramming highlights the epigenetic
plasticity of the somatic cell state. Long noncoding
RNAs (lncRNAs) have emerging roles in epigenetic
regulation, but their potential functions in reprogram-
ming cell fate have been largely unexplored.We used
single-cell RNA sequencing to characterize the
expression patterns of over 16,000 genes, including
437 lncRNAs, during defined stages of reprogram-
ming to pluripotency. Self-organizing maps (SOMs)
were used as an intuitive way to structure and
interrogate transcriptome data at the single-cell
level. Early molecular events during reprogramming
involved the activation of Ras signaling pathways,
along with hundreds of lncRNAs. Loss-of-function
studies showed that activated lncRNAs can repress
lineage-specific genes, while lncRNAs activated in
multiple reprogramming cell types can regulate
metabolic gene expression. Our findings demon-
strate that reprogramming cells activate defined
sets of functionally relevant lncRNAs and provide a
resource to further investigate how dynamic changes
in the transcriptome reprogram cell state.
INTRODUCTION
Normal embryonic development proceeds through a progres-
sive narrowing of cell fate potential and loss of cellular plasticity,
coupled with the acquisition of increasingly specialized, mature
cell phenotypes (Hemberger et al., 2009). This progression is re-
flected in the changing transcriptome and is driven by transcrip-
tion factors and noncoding RNAs, which comprise a regulatory
network that is highly resistant to perturbation. Various classes
of noncoding regulatory RNAs, including long noncoding RNAs
(lncRNAs) (Lee, 2012; Rinn and Chang, 2012) and small RNAs
(e.g., Piwi-interacting RNAs) (Law and Jacobsen, 2010; Moazed,
2009), contribute to the establishment of epigenetic chromatin
marks that stabilize cell state. Thus, to reprogram the somatic
identity of a cell, the combined effects of epigenetic and regula-
tory circuit stability must be overcome.88 Cell Stem Cell 16, 88–101, January 8, 2015 ª2015 Elsevier Inc.Induced reprogramming to the pluripotent state can be initi-
ated by the enforced expression of Oct4, Sox2, Klf4, and Myc
(OSKM) (Takahashi and Yamanaka, 2006). These factors act in
conjunction with other transcription factors and multiple chro-
matin-modifying enzymes (Onder et al., 2012) to initiate a
cascade of changes that ultimately convert a somatic cell of
limited potential to the pluripotent state (Apostolou and Hoched-
linger, 2013; Papp and Plath, 2013; Theunissen and Jaenisch,
2014). Apart from induced pluripotent stem cell (iPSC) reprog-
ramming, these defined factors and chromatin regulators have
also been shown to facilitate malignant transformation and pro-
gression, which might be viewed as a form of pathological re-
programming (Goding et al., 2014; Suva` et al., 2013). For
example, the catalytic subunit of Polycomb repressive complex
2 (PRC2), Ezh2, enhances the reprogramming potency of OSKM
(Buganim et al., 2012) and is also overexpressed in multiple
malignancies, including metastatic prostate cancer (Varambally
et al., 2002) and lymphomas (Laugesen and Helin, 2014). PRC2
physically associates with lncRNAs in embryonic stem cells
(ESCs) (Guttman et al., 2011; Zhao et al., 2010) and other cell
types, and lncRNAs such as Xist and HOTAIR guide PRC2 com-
plexes to their genomic targets (Rinn and Chang, 2012). Notably,
loss of Xist can lead to the development of hematologic cancer
(Yildirim et al., 2013), while HOTAIR overexpression can facilitate
breast cancer metastasis (Gupta et al., 2010). However, only
a small fraction of the thousands of mostly uncharacterized
lncRNAs are known to affect cell state (Flynn and Chang,
2014), and the ways in which they do so are not fully understood.
At this early stage of understanding, a clearer and more compre-
hensive portrait of lncRNA expression could provide missing
information on how a cell overrides its starting identity and rede-
fines a new one, whether in the context of OSKM reprogramming
or cellular transformation.
Insights intomany aspects of reprogramming are sought at the
single-cell level (Buganim et al., 2012; Polo et al., 2012; Smith
et al., 2010) because each cell reveals a possibly unique expres-
sion state, with its particular repertoire of regulatory factors and
target gene behavior. To gain a transcriptome-level understand-
ing of how individual cells are reprogrammed, we used single-cell
RNA sequencing (RNA-seq) (Ramsko¨ld et al., 2012), augmented
by single-molecule RNA-fluorescent in situ hybridization
(smFISH) (Raj et al., 2008). Further analysis of induced lncRNAs
identified distinct groups with possible roles in suppressing
somatic cell identity, conferring greater cellular plasticity, or
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periments of induced lncRNAs provided evidence for specific
repression of genes characteristic of mature cell fates or regula-
tion of genes involved in metabolic functions. We suggest that
lncRNAs identified in the context of somatic cell reprogramming
may also act in pathological reprogramming, especially in can-
cers that engage other parts of the OSKM pathway.
RESULTS
Single-Cell Analysis of the Reprogramming
Transcriptome
Weperformed single-cell RNA-seq on cells derived from the ‘‘re-
programmable’’ mouse (Figure 1A) (Carey et al., 2010). Tail-tip
fibroblasts (TTFs) from OSKM transgene-inducible mice were
cultured in the presence of doxycycline (dox) under ESC culture
conditions for 2 weeks. Flow cytometry analysis revealed that
these transgene-expressing cells (Figure S1A available online),
which we refer to as transitional cells, did not yet express the
SSEA1 antigen (Figure S1B). After 3 weeks of dox exposure,
we obtained early-stage iPSCs that expressed SSEA1 (Fig-
ure S1B), exhibited ESC-like morphology (Figure S1C), and
had single-cell cloning efficiencies of 50% when compared
to ESCs (Figure S1D). We then cultured these early-stage iPSCs
in the absence of dox for 4–6 additional weeks to profile the tran-
scriptomes of late-stage iPSCs, along with pluripotent ESCs.
Together, we generated 81 single-cell RNA-seq data sets (14–
21 libraries per cell type) at a sequencing depth of 5–10 million
mapped reads per cell. This unbiased experimental approach
allowed us to detect and characterize the expression patterns
of over 16,000 protein-coding and noncoding genes, including
lncRNAs.
We analyzed these high-dimensional data using a self-orga-
nizing map (SOM) (Figure S2), which provides an intuitive way
to visualize and interrogate single-cell heterogeneity based on
the behavior of coordinately expressed gene sets. The SOM
displays similarity relationships in a 2D heat map in which
spatial proximity reflects expression pattern similarity. We map-
ped 16,113 genes expressed at >10 reads per kilobase per
million mapped reads (RPKM) onto a SOM, where each hexag-
onal unit represents a set of genes whose expression patterns
are most similar to each other. These units are then clustered
and are located in the same fixed positions across all single-
cell components of the SOM. Each single-cell transcriptome
can then be visualized as a component of the SOM (Figure 1A,
five representative single-cell components shown for each cell
type).
To examine how individual transcriptomes from different
experimental time points were related, we performed principal-
component analysis (PCA), which revealed a clear separation
between (1) TTFs and transitional cells and (2) early- and late-
stage iPSCs and ESCs when projected onto the first two prin-
cipal components (Figure 1B). We next examined genes with
the highest correlation to Oct4 expression and identified many
genes expected to be involved in reprogramming and pluripo-
tency, including Nanog, Cdh1, Tdh, Utf1, Sall4, Tet1, Rex1,
Trim71, Fbxo15, Dppa2, Tcl1, and Tcfcp2l1 (Figure 1C) (Orkin
and Hochedlinger, 2011). The single-cell RNA-seq data also
allowed us to identify genes of potential interest that may alsocontribute to somatic cell reprogramming (Figure 1C). Many of
the genes that correlated most strongly with Oct4 expression
were heterogeneously expressed at lower levels in transitional
cells but then became coherently expressed at higher levels in
both early- and late-stage iPSCs (Figure 1C). To examine all pro-
tein-coding genes that were specifically activated upon OSKM
induction, we performed hierarchical clustering on genes that
were expressed at >10 RPKM in transitional cells and iPSCs,
while being expressed at <10 RPKM in primary TTFs. This group
included 1,835 protein-coding genes (Figure 1D).
Activation of Ras Signaling Pathways during
Reprogramming
To examine how individual cells responded to OSKM induction,
we analyzed single-cell components of the SOM. After 2 weeks
of OSKM expression, transitional cells strongly expressed a
cluster of genes (cluster 0) that was significantly enriched for
the Gene Ontology (GO) term ‘‘Ras protein signal transduction’’
(Bonferroni-corrected p value: 5.503 104) (Figure 2). Thirty-five
genes were annotated to this GO term, includingNrg1, which en-
hances self-renewal and proliferation of tumor-initiating cells
(Lee et al., 2014), andGit1 (Huang et al., 2014) and Rap1a (Bailey
et al., 2009), which are involved in cancer cell metastasis. Nine-
teen lncRNAs (Table S1) were also coordinately expressed with
these genes, suggesting their possible involvement in the regu-
lation of Ras signaling pathways. Additionally, transitional cells
exhibited strong upregulation of 16 lncRNAs (Table S1) within a
cluster of genes (cluster 21) significantly enriched for the GO
term ‘‘regulation of signal transduction’’ (Bonferroni-corrected
p value: 5.553 103) (Figure 2). One hundred genes were anno-
tated to this term, such as the oncogenesMyc andHras1 and the
Ras activator Rasgrp3 (Yang et al., 2010). One cluster in partic-
ular (cluster 24) was significantly enriched for the GO term
‘‘intracellular signal transduction’’ (Bonferroni-corrected p value:
3.52 3 107) (Figure 2) and contained numerous Ras-related
genes, including Rras, Rheb, and several members of the Ras
oncogene family (e.g., Rab2a, Rab11a) and Ras homolog family
(e.g., Rhog, Rhoa, Rhoc, Rhoq) of genes (Karnoub and Wein-
berg, 2008). Taken together, these results show that activation
of Ras signaling pathways and associated lncRNAs are early
molecular events in this reprogramming paradigm.
Coordinate Expression of Pluripotency Factors and
Noncoding Genes
Early-stage iPSCs strongly expressed numerous pluripotency
factors and related genes in one prominent cluster (cluster 7),
including Oct4, Sox2, Nanog, Lin28a, Rex1, Esrrb, Lifr, Fbxo15,
Sall4, Epcam, Dppa2, Dnmt3l, Tet1, Jarid2, Klf5, Trim71, Nodal,
Tcfcp2l1, Tcl1, Cdh1, Tdh, Utf1, and Eras (Figure 2). However,
the most significantly enriched GO term in this cluster was for
‘‘unannotated’’ (Bonferroni-corrected p value: 0) and included
285 noncoding genes of unknown function, underscoring the
need for a more in-depth characterization of the noncoding tran-
scriptome. Among these genes were 29 lncRNAs (Table S1) and
27 processed transcripts, which are also classified as a type of
lncRNA in the Ensembl annotation (Flicek et al., 2014), as well
as numerous pseudogenes. A nearby cluster (cluster 2) in the
SOM also contained the Meg3 and Rian lncRNAs, along with
32 additional lncRNAs (Table S1), Klf4, and Kras. Moreover,Cell Stem Cell 16, 88–101, January 8, 2015 ª2015 Elsevier Inc. 89
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Single-Cell Analysis of lncRNAs in Reprogrammingtwo clusters (cluster 9, cluster 10) directly adjacent to the plurip-
otency cluster (cluster 7) were significantly enriched for the core
PRC2 components Ezh2, Suz12, and Eed and 14 lncRNAs (Fig-
ure 2 and Table S1). Taken together, these results demonstrate
that early-stage iPSCs exhibit a significant upregulation of hun-
dreds of noncoding genes, including lncRNAs, whose reprog-
ramming functions are largely unknown.
lncRNAs Activated during Reprogramming
To systematically characterize the expression patterns of
lncRNAs activated during reprogramming (Ladr), we focused
further analysis on the lncRNA transcriptome. We mapped 437
lncRNAs expressed at >10 RPKM onto a new, lncRNA-specific
SOM (Figure 3A, five representative single-cell components
shown for each cell type) to assess single-cell heterogeneity
and to analyze individual lncRNA variation. Of the 437 lncRNAs,
we identified 312 activated lncRNAs that were expressed at >10
RPKM in transitional cells and/or iPSCs and ESCs, while being
expressed at <10 RPKM in TTFs (Figure 3B and Table S2),
indicating the dynamic nature of the lncRNA landscape during
somatic cell reprogramming.
To assess the potential functions of activated lncRNAs, we
first examined previously identified catalogs of Polycomb-asso-
ciated lncRNAs (Guttman et al., 2011; Zhao et al., 2010). This re-
vealed substantial overlap between the PRC2 transcriptome and
activated lncRNAs (n = 150) (Figure 4A and Table S3), suggesting
that many of these Polycomb-bound lncRNAs may repress
developmental genes. Although several coherent clusters of
PRC2-bound lncRNAs were strongly upregulated in early- and
late-stage iPSCs relative to transitional cells, hierarchical clus-
tering analysis suggested that these lncRNAs were heteroge-
neously expressed in individual cells. To examine whether this
apparent heterogeneity could be attributed mainly to technical
noise or to biological variation, we calculated the coefficient of
variation (CV) for lncRNAs expressed in late-stage iPSCs and
determined the relationship between the CV and mean expres-
sion level. Numerous lncRNAs (e.g., Ladr83, Ladr91, Ladr55,
Ladr1, Rian,Meg3) exhibited greater variability when compared
to the average noise for a given mean expression level, strongly
suggesting that biological variation is indeed elevated for these
lncRNAs (Figure 4B). Consistent with our single-cell RNA-seq
analysis, clonal iPSC lines exhibit functionally relevant heteroge-
neity in Meg3 lncRNA expression, where iPSC lines that lack
Meg3 expression are unable to generate all-iPSCmice (Stadtfeld
et al., 2012).
Wealso examined single-cell lncRNAheterogeneity at the tran-
scriptome- and single-molecule levels using the lncRNA SOM
and smFISH, respectively. For the lncRNA SOM, we calculated
the component (single-cell) variance for each hexagonal cluster
of lncRNA genes (Figure 4C). The lncRNA Ladr83 mapped to aFigure 1. Single-Cell Transcriptome Analysis of Cellular Reprogrammi
(A) Schematic illustration of reprogramming experiments and single-cell RNA-
components are shown for each cell type.
(B) Principal component (PC) analysis of 81 single-cell transcriptomes using all p
(C) Heatmap of protein-coding genes that correlate most highly (Pearson correla
(D) Hierarchical clustering of activated protein-coding genes during the reprogram
RPKM in all TTFs.
See also Figure S1.cluster with high variance, while Ladr49 mapped to a lower
variance cluster (Figure 4C; Figures S3A and S3B). We validated
these lncRNA SOM results using smFISH as an orthogonal
approach to determine the number of Ladr83 and Ladr49
molecules in hundreds of cells (n = 351) (Figure 4D). Ladr83 was
more heterogeneously expressed in both early- and late-stage
iPSCs relative to ESCs, with a subset of late-stage iPSCs ex-
pressing high levels of Ladr83 (61–113 lncRNA molecules/cell)
when compared to ESCs (median: 14 lncRNA molecules/cell).
However, the distributions of Ladr49 expression in both early-
and late-stage iPSCs were indistinguishable from ESCs (Fig-
ure 4E). Taken together, these results demonstrate the utility of
the SOM in characterizing cell-to-cell variation and suggest that
definedsetsof lncRNAsareheterogeneously expressed in iPSCs.
Suppression of Lineage-Specific Genes by Activated
lncRNAs
To examine the functional roles of Ladr49 and Ladr83, we used a
pool of 2–4 small interfering RNAs (siRNAs) per lncRNA to knock
down their expression levels in late-stage iPSCs (Figure S4A).
While knockdown of Ladr49 or Ladr83 had modest effects on
reprogramming efficiencies (Figure S4B), Ladr49 knockdown
resulted in the upregulation of muscle-related genes in iPSCs
(Figure 5A). GO analysis revealed significant enrichment for
the terms ‘‘contractile fiber,’’ ‘‘sarcomere,’’ and ‘‘striated muscle
thin filament.’’ These muscle-related genes were strongly ex-
pressed in TTFs and clustered together in the SOM, while they
were expressed at low levels in late-stage iPSCs (Figure 5B).
These results indicate that Ladr49 is required to repress a subset
of the myogenic program during somatic cell reprogramming.
Notably, Ladr83 knockdown resulted in the upregulation of
muscle genes that were also upregulated upon Ladr49 loss-of-
function (Figure 5C), suggesting that lncRNAs may act coopera-
tively and/or redundantly during cell fate reprogramming.
However, both Ladr83 and Ladr49 knockdowns did not signifi-
cantly perturb expression levels of the reprogramming and
pluripotency genes Oct4, Sox2, Klf4, Myc, Lin28, and Nanog
(Figure 5C), consistent with a specific role for these lncRNAs in
repressing developmental genes during reprogramming. When
we analyzed the differential expression of all Ensembl-annotated
lncRNAs in populations of ESCs and TTFs by RNA-seq, Ladr49
and Ladr83 were among the 48 most significantly upregulated
lncRNAs in ESCs versus TTFs (Figure 5D). Twenty-two of these
lncRNAs (46%), including Ladr49 and Ladr83, were previously
shown to physically associate with PRC2 (Guttman et al.,
2011; Zhao et al., 2010) (Figure 5E), suggesting that other
PRC2-bound lncRNAs are likely to have functional roles in
regulating lineage-specific genes.
To examine the cell-type specificity of activated lncRNAs, we
also analyzed the transcriptome data from iPSCs derived fromng
seq analysis using the self-organizing map (SOM). Five representative SOM
rotein-coding genes expressed at >1 RPKM.
tion) with Oct4 expression during the reprogramming time course.
ming time course using genes expressed at >10 RPKM in non-TTFs and <10
Cell Stem Cell 16, 88–101, January 8, 2015 ª2015 Elsevier Inc. 91
Figure 2. Analysis of Transcriptome Dynamics Using the Self-Organizing Map
Single-cell transcriptomes depicted as individual components of the self-organizing map (SOM). Boxes represent individual cells at defined stages of re-
programming, with clusters outlined in white. Significantly enriched Gene Ontology (GO) terms for indicated clusters are shown (Bonferroni-corrected p values).
See also Figure S2 and Table S1.
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Figure 3. lncRNAs Activated during Reprogramming
(A) Schematic illustration of lncRNAs activated during defined stages of reprogramming (>10 RPKM) and lncRNA transcriptome analysis using the self-organizing
map (SOM). Five representative SOM components are shown for each cell type.
(B) Hierarchical clustering of activated lncRNA genes during the reprogramming time course using genes expressed at >10 RPKM in non-TTFs and <10 RPKM in
all TTFs. See also Table S2.
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Figure 4. Activated lncRNA Expression Variability in iPSCs
(A) Heatmap of activated lncRNAs previously shown to physically associate with Polycomb repressive complex 2 in pluripotent stem cells.
(B) Plot showing the relationship between average lncRNA expression and coefficient of variation in single late-stage iPSCs.
(legend continued on next page)
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Single-Cell Analysis of lncRNAs in ReprogrammingCD117+ hematopoietic progenitor cells (HPCs) (Chang et al.,
2014). One hundred and thirty lncRNAs were significantly upre-
gulated during HPC reprogramming into iPSCs (Figure 6A),
with 64 lncRNAs overlapping with the activated lncRNAs that
we characterized during TTF reprogramming (Figure 6B). Of
the remaining 66 lncRNAs specifically activated in HPC-iPSCs
(Table S2), we examined one lncRNA in particular, Ladr317, us-
ing smFISH in early- and late-stage iPSCs derived from TTFs
(Figure 6C). Ladr317 was expressed at both stages, with lower
levels in early-stage iPSCs relative to ESCs. However, late-stage
iPSCs exhibited comparable levels of Ladr317 when compared
to ESCs. Loss-of-function experiments in late-stage iPSCs re-
vealed that Ladr317 is required to repress genes involved in
interferon signaling: Irgm1, Usp18, and Ifit3 (Figure 6D), consis-
tent with a functional role in repressing hematopoietic lineage-
specific genes. When we examined lncRNAs activated during
HPC reprogramming in our single-cell data from TTF reprogram-
ming, only a small fraction of these lncRNAs were expressed in
TTF-iPSCs (Figure 6E), suggesting that most of these lncRNAs
are not involved in silencing fibroblast lineage genes.
Regulation of Metabolic Genes by Activated lncRNAs
To explore the potential functions of lncRNAs activated in
multiple reprogramming cell types, we performed hierarchical
clustering on lncRNAs upregulated in both TTF-iPSCs and
HPC-iPSCs. Many of these overlapping lncRNAs were strongly
upregulated in early- and late-stage TTF-iPSCs (Figure 7A), in
contrast to the same analysis performed using lncRNAs specific
to HPC reprogramming (Figure 6E). We selected two of these
robustly expressed lncRNAs for loss-of-function analysis, based
additionally on their sequence conservation in the human
genome (Figure S5A) (Kuhn et al., 2013) and their high correlation
with Oct4 expression (Figure S5B). Knockdown of either Ladr86
or Ladr91 (Figures S3C, S3D, and S4A) repressed a common set
of mitochondrial genes. Downregulated genes in both experi-
ments were enriched for the GO terms ‘‘membrane-bounded
organelle’’ and ‘‘mitochondrion’’ (Figures 7B and 7C), suggesting
that these lncRNAs are involved in regulating metabolic aspects
of reprogramming in at least two different lineages and perhaps
very broadly.
DISCUSSION
Normal somatic cells are understood to have restricted develop-
mental and epigenetic plasticity (Hemberger et al., 2009). Multi-
ple mechanisms stabilize the mature cell state and must be
overcome during cellular reprogramming. To examine regulators
of cell state conversion, we measured the transcriptomes of in-
dividual cells at defined stages of reprogramming to pluripo-
tency. As shown in earlier studies (Apostolou and Hochedlinger,
2013; Papp and Plath, 2013; Theunissen and Jaenisch, 2014),
we observed coordinated expression of known OSKM pathway
genes in early- and late-stage iPSCs, while identifying additional
coexpressed protein-coding and lncRNA genes.(C) Individual cell components of the lncRNA SOM (left) and component varianc
(D) Representative phase contrast (merged with fluorescence) and fluorescence
(E) Cumulative distribution function plots of lncRNA molecules per cell, as determ
See also Figure S3 and Table S3.Activation of many lncRNA and Ras-related genes are early
molecular events that are prominent in transitional cells. While
the significance of this observation is yet to be established, find-
ings from other systems suggest that such mechanisms might
be common to multiple reprogramming systems. For example,
reprogramming by somatic cell nuclear transfer (SCNT) (Gurdon
and Melton, 2008) may also involve lncRNA and Ras-related
genes upregulated in our transitional cells, based on mapping
oocyte single-cell RNA-seq data onto our SOM (Figures 2 and
S2B) (Ramsko¨ld et al., 2012). Similarities between SCNT and
iPSC reprogramming are also highlighted by iPSC activation of
germ cell-related genes (Figures S6A–S6C) and expression of
Piwi-interacting RNA (piRNA)-like small RNAs (Figures S6D–
S6F), which are also detected in oocytes (Tam et al., 2008) and
human iPSCs (Marchetto et al., 2013). Given their known
functions in imprinting (Watanabe et al., 2011) and epigenetic
regulation (Stuwe et al., 2014), piRNAs may also be involved
in regulating imprinted loci during reprogramming. Because
SCNT-derived pluripotent stem cells have less epigenetic and
imprinting defects than iPSCs, investigating oocyte-enriched
noncoding RNAs in OSKM-mediated reprogramming may pro-
vide insights for minimizing unwanted epigenetic signatures.
Our loss-of-function experiments argue that at least some
OSKM-induced lncRNAs are functionally relevant in reprogram-
ming. We have shown that individual lncRNAs are required
to properly silence lineage-specific genes. OSKM-induced vari-
ation in lncRNA expression levels, however, might contribute to
a form of ‘‘epigenetic memory’’ in iPSCs (Kim et al., 2010; Polo
et al., 2010). For example, lower levels of Ladr49, generated by
experimental knockdown, gave elevated expression of specific
muscle-related genes in iPSC populations. Failure to activate
Ladr49 in iPSCs might introduce a bias favoring muscle deriva-
tives and/or produce an inappropriate mixed phenotype. This
scenario is consistent with prior reports that differences in
OSKM stoichiometry during reprogramming can produce vary-
ing and functionally relevant effects on the expression of specific
imprinted lncRNAs (Carey et al., 2011; Stadtfeld et al., 2010).
OSKM-mediated reprogramming also results in the elevated
expression of specific lncRNAs in iPSCs relative to ESCs (Fig-
ure 4E) (Loewer et al., 2010), but the functional consequences
of these observations are unclear. One potential role for
such lncRNAs is suggested by studies of lincRNA-RoR, which
is required for iPSC reprogramming (Loewer et al., 2010).
LincRNA-RoR acts as a repressor of the tumor suppressor
gene p53 (Zhang et al., 2013), conferring reprogrammed cells
with the ability to overcome p53-mediated apoptosis. p53
inactivation, whether through genetic mutation or experimental
perturbation, promotes cancer and somatic cell reprogramming
(Krizhanovsky and Lowe, 2009). Additionally, leukemia cells acti-
vate the expression of many unannotated lncRNAs that are regu-
lated by oncogenic Notch signaling (Trimarchi et al., 2014). We
also found that perturbing signaling pathways in iPSCs under
‘‘2i’’ conditions (Mek and Gsk3 inhibition) (Ying et al., 2008) acti-
vates a unique set of lncRNAs (Figure S7). Collectively, thesee for each hexagonal unit of the lncRNA SOM (right).
images of a single early-stage iPSC using smFISH. Scale bar, 10 mm.
ined by smFISH.
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Figure 5. Repression of Developmental Genes by Ladr49 and Ladr83
(A) Differential expression analysis of significantly upregulated or downregulated genes in late-stage iPSCs deficient for Ladr49, as determined by population level
RNA-seq, and Gene Ontology (GO) analysis for significantly enriched GO terms in upregulated genes. Bonferroni-corrected p values are shown.
(B) Individual cell SOM components of indicated cell types with muscle-related genes labeled.
(C) Effective read counts (normalized reads) for muscle-related (top) and reprogramming and pluripotency (bottom) genes in late-stage iPSCs, as determined by
population level RNA-seq.
(D) Differential expression analysis of significantly upregulated or downregulated lncRNA genes in ESCs versus TTF cells, as determined by population level
RNA-seq.
(E) Fraction of upregulated or downregulated lncRNAs that is physically associated with Polycomb repressive complex 2 in ESCs.
See also Figure S4.
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Figure 6. Lineage-Specific Role for Ladr317 in Hematopoietic Reprogramming
(A) Differential expression analysis of significantly upregulated or downregulated lncRNA genes in HPC versus HPC-iPSCs, as determined by population level
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Single-Cell Analysis of lncRNAs in Reprogrammingresults suggest that lncRNAs activated during reprogramming
might also participate in oncogenic signaling pathways. Finally,
we identified Ladr lncRNAs that are activated in multiple reprog-
ramming cell types. Loss-of-function experiments for Ladr86
and Ladr91 affected genes acting in mitochondrial functions,
including electron transport (Figures 7B and 7C). While the
downstream consequences are unknown, a prior study linked
aberrant mitochondrial membrane potential in pluripotent stem
cells with elevated teratoma frequency (Schieke et al., 2008).
Taken together, our results suggest a model in which somatic
cells activate lineage-specific lncRNAs to repress develop-
mental genes, while also upregulating a common set of lncRNAs
that facilitate metabolic reprogramming in a lineage-indepen-
dent manner (Figure 7D). Our single-cell transcriptome analysis
of induced pluripotency provides a resource to further examine
the molecular mechanisms by which lncRNAs reprogram so-
matic cell state. In addition to lncRNAs, other classes of non-
coding genes, such as pseudogenes, are also activated during
reprogramming and have emerging roles in cancer development
(Cooke et al., 2014; Han et al., 2014). Further studies of the
noncoding transcriptome in various reprogramming contexts
are likely to advance our basic understanding of cell state plas-
ticity and cellular transformation.
EXPERIMENTAL PROCEDURES
iPSC Reprogramming
Tail-tip fibroblast (TTF) cultures were established from 3- to 8-day-old reprog-
rammable mice homozygous for both the tet-inducible OSKM polycistronic
cassette and the ROSA26-M2rtTA allele (Carey et al., 2010). Maintenance of
animals and tail tip excision were performed according to a mouse protocol
approved by the Caltech Institutional Animal Care and Use Committee
(IACUC). TTFs (+ doxycycline), iPSCs, and ESCswere cultured in ESCmedium
(Dulbecco’s modified Eagle’s medium, 15% fetal bovine serum, sodium
bicarbonate, HEPES, nonessential amino acids, penicillin-streptomycin,
L-glutamine, b-mercaptoethanol, 1000 U/ml LIF) and grown on 6-well plates
coated with 0.1% gelatin and irradiated MEF feeder cells (GlobalStem). For
‘‘2i’’ conditions, iPSCs were grown in ESGRO-2i medium (Millipore). For
lncRNA loss-of-function, iPSCs were transfected with siRNAs (Integrated
DNA Technologies) using Lipofectamine RNAiMAX (Life Technologies). For
SSEA-1 detection, StainAlive SSEA-1 DyLight 488 antibody (Stemgent) was
used to detect SSEA-1 positive cells at specified time points during reprog-
ramming, which were isolated using flow cytometry on an iCyt Mission Tech-
nology Reflection Cell Sorter inside a Baker Bioguard III biosafety cabinet.
Single-Cell and Bulk Sample cDNA Synthesis and Amplification
cDNA synthesis was performed using the Smart-Seq protocol as previously
described (Ramsko¨ld et al., 2012). Briefly, the SMARTer Ultra Low RNA kit
for Illumina sequencing (Clontech Laboratories) was used to generate and
amplify cDNA from single cells isolated using a micromanipulator or from
bulk samples. Intact single cells were deposited directly into hypotonic lysis
buffer. Poly(A)+ RNA was reverse transcribed through oligo dT priming to
generate full-length cDNA, which was then amplified using 20–22 cycles.
cDNA length distribution was assessed using High Sensitivity DNA kits on
a Bioanalyzer (Agilent Technologies), and only samples showing a broad
length distribution peak centered at 2 kb were subsequently used for library
generation.(C) Representative phase contrast (merged with fluorescence) and fluorescence i
function plots of lncRNA molecules per cell, as determined by smFISH. Scale ba
(D) Differential expression analysis of significantly upregulated or downregulated
level RNA-seq.
(E) Hierarchical clustering of lncRNAs activated in HPC-iPSCs, as determined by
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Sequencing
Single-cell and bulk sample RNA-seq libraries were constructed using the Nex-
tera DNA Sample Prep kit (Illumina). Briefly, cDNA was ‘‘tagmentated’’ at 55C
with Nextera transposase, and tagmented DNA was purified using Agencourt
AMPureXPbeads (BeckmanCoulterGenomics). PurifiedDNAwasamplifiedus-
ingfivecyclesofNexteraPCR,and libraryqualitywasassessedusingHighSensi-
tivityDNAkitsonaBioanalyzer (Agilent).Librariesweresequencedonthe Illumina
HiSeq2000. Single-end reads of 50 bp or 100 bp length were obtained.
Read Mapping and Expression Quantification
All reads were trimmed down to 50 bp (if necessary) andmapped to themouse
genome (version mm9) with TopHat (Trapnell et al., 2009) (version 1.2.1) while
supplying splice junctions annotated in the ENSEMBL63 set of transcript
models. RPKMs for the ENSEMBL63 annotation were obtained using Cufflinks
(Trapnell et al., 2010) (version 1.0.3) with otherwise default settings. For down-
stream analysis, the biotype classification of genes and transcripts in the
ENSEMBL annotation was used to identify noncoding genes. Hierarchical
clustering was carried out using Cluster 3.0 (de Hoon et al., 2004) and visual-
ized using Java Treeview (Saldanha, 2004). For differential expression anal-
ysis, we aligned reads against the refSeq mouse transcriptome using Bowtie
version 0.12.7 (Langmead et al., 2009). Expression levels were then estimated
using eXpress (Roberts and Pachter, 2013) (version 1.3.0), with gene-level
effective counts and RPKM values derived from the sum of the corresponding
values for all isoforms of a gene. The effective count values were then used as
input to DESeq (Anders and Huber, 2010) to assess differential expression.
For chromatin immunoprecipitation sequencing analysis, sequencing data
were downloaded from NCBI Gene Expression Omnibus accession numbers
GSM307140, GSM623989, GSM307137, GSM307138, GSM307155, and
GSM623991 and EMBL European Bioinformatics Institute accession number
E-MTAB-1600. Reads were extracted using the fastq-dump program in the
SRA ToolKit and mapped to the mm9 version of the mouse genome using
Bowtie 0.12.7 with the following settings: ‘‘-v 2 -k 2 -m 1 -t–best–strata,’’
i.e., retaining only unique reads and allowing for up to two mismatches in a
read. Enriched regions were called using ERANGE 3.2 (Johnson et al., 2007)
with the following settings: ‘‘-minimum 2 -ratio 3 -shift learn -revbackground.’’
Self-Organizing Maps
The 5,000 genes with the greatest variance among the libraries were used for
training a self-organizing map. Prior to SOM training, the data vectors were
normalized on a gene-by-gene basis by subtracting each vector mean and
dividing by its standard deviation. The SOMwas constructed using the R pack-
age ‘‘kohonen.’’ The total number of map units was set to the heuristic value
53sqrt(N), where N is the number of data vectors. The map grid was initialized
with the first two principal components of the data multiplied by a sinusoidal
function to yield smooth toroidal boundary conditions. Training lasted 200
epochs (presentations of the data), during which the radius within which units
were adapted toward the winning unit decreased linearly from h/8 to 2 units,
where h is the map height (always chosen as the direction of largest length).
Further analysis, including clustering and visualization, was performed with
custom python code. Clusters were seeded by the local minima of the u-ma-
trix, with a value for each unit defined as the average of the vector difference
between that unit’s prototype and its six neighbors on the hexagonal grid.
All other unit prototypes were then assigned to clusters according to the min-
imum vector distance to a seed unit. The lists of clustered genes were submit-
ted to the Princeton GO TermFinder (Boyle et al., 2004) server (http://go.
princeton.edu) in order to determine enriched terms.
Single-Molecule Fluorescence In Situ Hybridization
smFISH was performed as previously described (Raj et al., 2008). Up to 48
DNA probes per target mRNA or lncRNA were synthesized and conjugatedmages of a single early-stage iPSC using smFISH, and cumulative distribution
r, 10 mm.
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single-cell RNA-seq. RPKM, reads per kilobase per million mapped reads.
B C
log (RPKM+1)
1        2        4        6        8       10
2
0
Tail-tip
fibroblasts
Transitional
cells
Early-stage
iPS cells
Late-stage
iPS cells
Embryonic
stem cells
Ladr91
Ladr86
A
110 210 3 4 105 1061010010
1
2
3
4
105
106
10
10
10
10
010
Population
RNA-seq
s
iL
ad
r9
1
(no
rm
ali
ze
d r
ea
ds
)
Control
(normalized reads)
Late-stage iPS cells
upregulated (P < 0.05)
downregulated (P < 0.05)
Chchd10
Ppif
Mrps24
Mpv17l2
Cox5a
Mrps34
Tomm40
Rbfa
C1qbp
Cyc1
Uqcrfs1
Enriched gene ontology term     Corrected P-value
mitochondrion                5.19 e-03
110 210 3 4 105 1061010010
1
2
3
4
105
106
10
10
10
10
010
Population
RNA-seq
s
iL
ad
r8
6
(no
rm
ali
ze
d r
ea
ds
)
Control
(normalized reads)
Late-stage iPS cells
upregulated (P < 0.05)
downregulated (P < 0.05)
Chchd10
Ppif
Mrps24
Mpv17l2
Cox5a
Mrps34Tomm40
Rbfa
C1qbp
Cyc1
Uqcrfs1
Enriched gene ontology term     Corrected P-value
membrane-bounded organelle               2.58 e-11                    
mitochondrion                1.70 e-04
Ln
cR
N
A
s 
ac
tiv
at
ed
 in
H
PC
-iP
S 
& 
TT
F-
iP
S 
(n
 = 
64
)
Fibroblast
(e.g. TTF)
lineage-specific
genes
(e.g. muscle-related)
lineage-specific
genes
(e.g. interferon-related)
metabolic
genes
(e.g. mitochondrial)
iPS cells
activated lncRNAs
Blood cell
(e.g. HPC)
D
+ OSKM
Figure 7. Regulation of Metabolic Genes by Ladr86 and Ladr91
(A) Hierarchical clustering of lncRNAs activated in both HPC-iPSCs and TTF-iPSCs, as determined by single-cell RNA-seq. RPKM, reads per kilobase per million
mapped reads.
(B and C) Differential expression analysis of significantly upregulated or downregulated genes in late-stage iPSCs deficient for Ladr86 (B) or Ladr91 (C), as
determined by population level RNA-seq, and Gene Ontology (GO) analysis for significantly enriched GO terms in downregulated genes. Bonferroni-corrected
p values are shown.
(D) Model showing lineage-specific and lineage-independent functions of activated lncRNAs during fibroblast and blood cell reprogramming.
See also Figures S5–S7 and Tables S4 and S5.
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Single-Cell Analysis of lncRNAs in Reprogrammingto Alexa fluorophore 488, 555, 594, or 647 (Life Technologies) and then purified
by HPLC. Cells were trypsinized, fixed in 4% formaldehyde, and permeabilized
in 70% ethanol overnight. Cells were then hybridized with the probe overnight
at 30C, in 20% formamide, 2X SSC, 0.1 g/ml dextran sulfate, 1 mg/ml E. coli
tRNA, 2 mM vanadyl ribonucleoside complex, and 0.1% Tween 20 in
nuclease-free water. Samples were washed twice in 20% formamide, 2X
SSC, and Tween 20 at 30C and then twice in 2X SSC+0.1% Tween at RT.
One microliter of hybridized cells was placed between #1 coverslips and flat-
tened. Automated grid-based acquisition was performed on a Nikon Ti-E with
Perfect Focus System, Semrock FISH filtersets, Lambda LS Xenona Arc
Lamp, 60x 1.4NA oil objective, and Coolsnap HQ2 camera. Semiautomated
dot detection and segmentation was performed using custom-built MATLAB
software with a Laplacian-of-Gaussian Kernel, using Otsu’s method to deter-
mine the ‘‘dotness’’ threshold across all cells in the data set.
Small RNA Sequencing and Analysis
Oxidation and beta-elimination of small RNAs were performed as previously
described (Ameres et al., 2010). The Illumina-compatible NEBNext Small
RNA Sample Prep Set 1 (New England Biolabs) was used to prepare small
RNA libraries for sequencing on the Illumina platform. Sequencing adapters
were removed from readsbyfinding the30-most completematch to theadaptor
sequence and trimming the read after that position. The resulting were first
mapped to the collection of ribosomal repeats (annotated using the Repeat-
Masker file downloaded from the UCSC genome browser), small nucleolar
RNAs, and small nuclear RNAs in the mouse genome (version mm9) using
Bowtie version 0.12.7 in order to remove common contaminant reads. The
unmapped reads from this filtering step were then aligned against the mm9
genome to determine the number of mappable reads. Both bowtie mapping
steps were carried out with the following settings: ‘‘-v 0 -a -t–best–strata,’’
i.e., nomismatches and an unlimited number of locations to which a read could
map to. Enrichment of repeat classes in sequencing was estimated by calcu-
lating RPM (reads per million mapped reads) scores for each individual repeat
annotated in theUCSCRepeatMasker file, then summing over all the instances
of each repeat class in order to derive a total repeat class RPM score.
ACCESSION NUMBERS
Sequencing data have been deposited in the National Center for Biotech-
nology Information Gene Expression Omnibus under accession number
GSE55291.
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